Dietary crystalline common-, micro-, nanoscale and emulsified nanoscale sitosterol reduce equally the cholesterol pool in guinea pigs, but varying nanosystems result in different sterol concentrations in serosal jejunum

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 9, Issue 7, 2013, Pages 1027-1035

  Jahreis, Gerhard ^a   Wohlgemuth, Steffen ^a   Grünz, Gregor ^a   Martin, Lena ^a   Knieling, Martin ^a   Engel, Robert ^b   Türk, Michael ^b   Keller, Sylvia ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Cholesterol; Nanosystem; Sitosterol

Indexed keywords

CHOLESTEROL LEVELS; FUNCTIONAL FOODS; GUT TISSUES; HIGH CHOLESTEROLS; HUMAN STUDY; HYPOCHOLESTEROLEMIC EFFECT; NANOSCALE-DISPERSION; SITOSTEROL;

ALCOHOLS; CHOLESTEROL; CRYSTALLINE MATERIALS; EMULSIFICATION; MAMMALS; NUTRITION;

NANOSYSTEMS;

CHOLESTEROL; SITOSTEROL; STEROL;

ANIMAL TISSUE; ARTICLE; CHOLESTEROL DIET; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIET; DIGESTION; DUNKIN HARTLEY GUINEA PIG; EMULSION; JEJUNUM; LIVER; NANOTECHNOLOGY; NONHUMAN; PLASMA; SEROSA;

ANIMALIA; CAVIA; RATTUS;

ACAT; ACYL-COA CHOLESTEROL ACYLTRANSFERASE; BASAL DIET; BD; CCS; CHOLESTEROL; CMLS; CMS; CNS; CRYSTALLINE COMMONSCALE SITOSTEROL; CRYSTALLINE MICROSCALE LOW SITOSTEROL; CRYSTALLINE MICROSCALE SITOSTEROL; CRYSTALLINE NANOSCALE SITOSTEROL; DM; DRY MATTER; EMULSIFIED NANOSCALE SITOSTEROL; ENS; HC; HIGH CHOLESTEROL; LDL; LOW DENSITY LIPOPROTEIN; NANOSYSTEM; NIEMANN-PICK C1 LIKE 1 TRANSPORTER; NPC1L1; SD; SITOSTEROL; STANDARD DEVIATION;

ANIMALS; CHOLESTEROL; CRYSTALLIZATION; DIET; EMULSIONS; FEMALE; GUINEA PIGS; HUMANS; JEJUNUM; LIVER; NANOPARTICLES; PARTICLE SIZE; RATS; SEROUS MEMBRANE; SITOSTEROLS;

EID: 84884290616     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2013.03.007     Document Type: Article

References (44)

1. Australian Government. Department of Innovation, Industrie, Science and Research. Final report. Australian community attitude held about nanotechnology - trends 2005 to 2011 [online]. (assessed November 09, 2012). http://www.innovation.gov.au/Industry/Nanotechnology/PublicAwarenessandEngagement/Documents/NanotechnologyPublicAwareness2011.pdf.
2. BfR consumer conference nanotechnology - pilot project to identify consumer risk perception 2009, 77. BfR Printing House Dahlem, Berlin. R. Zimmer, R. Hertel, G.F. Böl (Eds.).
3. Scientific Committee. Scientific opinion. The potential risks arising from nanoscience and nanotechnologies on food and feed safety. EFSA J 2009, 958:1-39. European Food Safety Authority.
4. Duncan T.V. The communication challenges presented by nanofoods. Nat Nanotechnol 2011, 6:683-688.
5. Siegrist M. Factors influencing public acceptance of innovative food technologies and products. Trends Food Sci Technol 2008, 19:603-608.
6. Sekhon B.S. Food nanotechnology - an overview. Nanotechnol Sci Appl 2010, 3:1-15.
7. Weiss J., Takhistov P., McClements D.J. Functional materials in food nanotechnology. J Food Sci 2006, 71:R107-R116.
8. Möller M., Eberle U., Hermann A., Moch K., Stratmann B. Nanotechnologie im Bereich der Lebensmittel 2009, Vdf Hochschulverlag ETH Zürich, Zürich.
9. Chaudhry Q., Scotter M., Blackburn J., Ross B., Boxall A., Castle L., et al. Applications and implications of nanotechnologies for the food sector. Food Addit Contam A 2008, 25:241-258.
10. Onwulata C.I. Encapsulation of new active ingredients. Annu Rev Food Sci Technol 2012, 3:183-202.
11. Micallef M.A., Garg M.L. Beyond blood lipids: phytosterols, statins, and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia. J Nutr Biochem 2009, 20:927-939.
12. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001, 285:2486-2497.
13. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
14. Brown A.W., Hang J., Dussault P.H., Carr T.P. Phytosterol ester constituents affect micellar cholesterol solubility in model bile. Lipids 2010, 45:855-862.
15. Jones P.J.H. Dietary agents that target gastrointestinal and hepatic handling of bile acids and cholesterol. J Clin Lipidol 2008, 2:S4-S10.
16. Calandra S., Tarugi P., Speedy H.E., Dean A.F., Bertolini S., Shoulders C.C. Mechanism and genetic determinants regulating sterol absorption, circulating LDL levels, and sterol elimination: implications for classification and disease risk. J Lipid Res 2011, 52:1885-1926.
17. Lin D.S., Steiner R.D., Merkens L.S., Pappu A.S., Connor W.E. The effects of sterol structure upon sterol esterification. Atherosclerosis 2010, 208:155-160.
18. Field F.J., Mathur S.N. ß-Sitosterol: esterification by intestinal acylcoenzyme A:cholesterol acyltransferase (ACAT) and its effect on cholesterol esterification. J Lipid Res 1983, 24:409-417.
19. Temel R.E., Gebre A.K., Parks J.S., Rudel L.L. Compared with acyl-CoA:cholesterol O-acyltransferase (ACAT) 1 and lecithin:cholesterol acyltransferase, ACAT2 displays the greatest capacity to differentiate cholesterol from sitosterol. J Biol Chem 2003, 278:47594-47601.
20. Nguyen T.M., Sawyer J.K., Kelley K.L., Davis M.A., Rudel L.L. Cholesterol esterification by ACAT2 is essential for efficient intestinal cholesterol absorption: evidence from thoraric lymph duct cannulation. J Lipid Res 2012, 53:95-104.
21. Sanclemente T., Marques-Lopes I., Puzo J., Garcia-Otin A.L. Role of naturally-occurring plant sterols on intestinal cholesterol absorption and plasmatic levels. J Physiol Biochem 2009, 65:87-98.
22. Law M. Plant sterol and stanol margarines and health. Brit Med J 2000, 320:861-864.
23. Wester I. Cholesterol-lowering effect of plant sterols. Eur J Lipid Sci Technol 2000, 102:37-44.
24. Musa-Veloso K., Poon T.H., Elliot J.A., Chung C. A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials. Prostag Leukotr Ess 2011, 85:9-28.
25. European Food Safety Authority Consumption of food and beverages with added plant sterols in the European Union. EFSA J 2008, 133:1-21.
26. European Commission. Scientific Committee on Food. General view of the Scientific Committee on Food on the long-term effects of the intake of elevated levels of phytosterols from multiple dietary sources, with particular attention to the effects on ß-carotene. Expressed on 26 September 2002 [online] (assessed November 09, 2012). http://ec.europa.eu/food/fs/sc/scf/out143_en.pdf.
27. Salen G., Shefer S., Nguyen L., Ness G.C., Tint G.S., Shore V. Sitosterolemia. J Lipid Res 1992, 33:945-955.
28. Assmann G., Cullen P., Erbey J., Ramey D.R., Kannenberg F., Schulte H. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: Results of a nested case-control analysis of the Prospective Cardiovascular Münster (PROCAM) study. Nutr Metab Cardiovas 2006, 16:13-21.
29. Kreuzer J. Phytosterols and phytostanols: is it time to rethink that supplemented margarine?. Cardiovasc Res 2011, 90:397-398.
30. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm Res 1997, 14:259-266.
31. Engel R., Schubert H. Formulation of phytosterols in emulsions for increased dose response in functional foods. Innov Food Sci Emerg Technol 2005, 6:233-237.
32. Tuerk M., Upper G., Hils P. Formation of composite drug-polymer particles by co-precipitation during the rapid expansion of supercritical fluids. J Supercrit Fluid 2006, 39:253-263.
33. Keller S., Helbig D., Härtl A., Jahreis G. Nanoscale and customary non-esterified sitosterols are equally enriched in different body compartments of the guinea pig. Mol Nutr Food Res 2007, 51:1503-1509.
34. Kawaguchi H., Miyoshi N., Miura N., Fujiki M., Horiuchi M., Izumi Y., et al. Microminipig, a non-rodent experimental animal optimized for Life Science research: Novel atherosclerosis model induced by high fat and cholesterol diet. J Pharmacol Sci 2011, 115:115-121.
35. Lefebvre P., Cariou B., Lien F., Kuipers F., Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009, 89:147-191.
36. Mussner M.J., Parhofer K.G., von Bergmann K., Schwandt P., Broedl U., Otto C. Effects of phytosterol ester-enriched margarine on plasma lipoproteins in mild to moderate hypercholesterolemia are related to basal cholesterol and fat intake. Metabolism 2002, 51:189-194.
37. Wang D.Q.H. Regulation of intestinal cholesterol absorption. Annu Rev Physiol 2007, 69:221-248.
38. Van der Wulp M.Y.M., Verkade H.J., Groen A.K. Regulation of cholesterol homeostasis. Mol Cell Endocrinol 2013, 368:1-16.
39. Fröhlich E., Roblegg E. Models for oral uptake of nanoparticles in consumer products. Toxicology 2012, 291:10-17.
40. Canton I., Battaglia G. Endocytosis at the nanoscale. Chem Soc Rev 2012, 41:2718-2739.
41. Awaad A., Nakamura M., Ishimura K. Imaging of size-dependent uptake and identification of novel pathways in mouse Peyer's patches using fluorescent organosilica particles. Nanomedicine 2012, 8:627-636.
42. Florence A.T., Sakthivel T., Toth I. Oral uptake and translocation of a polylysine dendrimer with a lipid surface. J Control Release 2000, 65:253-259.
43. Desai M.P., Labhasetwar V., Amidon G.L., Levy R.J. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996, 13:1838-1845.
44. Ntanios F.Y., van de Kooij A.J., De Deckere E.A.M., Duchateau G.S.M.J.E., Trautwein E.A. Effects of various amounts of dietary plant sterol esters on plasma and hepatic sterol concentration and aortic foam cell formation of cholesterol-fed hamsters. Atherosclerosis 2003, 169:41-50.